| Product Code: ETC13272939 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Endoscopic Hemostasis Market was valued at USD 1.8 Billion in 2024 and is expected to reach USD 3.1 Billion by 2031, growing at a compound annual growth rate of 7.20% during the forecast period (2025-2031).
The global endoscopic hemostasis market is witnessing steady growth driven by an increasing prevalence of gastrointestinal bleeding disorders, advancements in endoscopic technologies, and a rise in minimally invasive procedures. The market is characterized by the growing adoption of endoscopic hemostasis techniques for the treatment of ulcers, varices, and other bleeding conditions. Key market players are focusing on developing innovative hemostasis devices and accessories to enhance procedural efficiency and patient outcomes. Geographically, North America and Europe dominate the market due to well-established healthcare infrastructure, while the Asia Pacific region is experiencing rapid growth attributed to improving healthcare facilities and rising awareness about endoscopic procedures. The market is expected to continue expanding as the demand for minimally invasive treatment options increases globally.
The Global Endoscopic Hemostasis Market is experiencing significant growth due to the increasing prevalence of gastrointestinal bleeding disorders, advancements in endoscopic technologies, and the rising demand for minimally invasive procedures. Key trends in the market include the adoption of advanced hemostatic agents and devices, the development of novel endoscopic hemostasis techniques, and the growing focus on early detection and treatment of bleeding lesions. Opportunities in the market lie in the expansion of endoscopic hemostasis procedures in emerging markets, the introduction of innovative products with enhanced efficacy and safety profiles, and the rising investment in research and development for new technologies. Overall, the Global Endoscopic Hemostasis Market is poised for continued growth driven by these trends and opportunities.
The Global Endoscopic Hemostasis Market faces several challenges, including the high cost of endoscopic procedures and equipment, limited access to advanced healthcare facilities in developing regions, and the risk of complications associated with endoscopic hemostasis procedures. Additionally, the lack of skilled professionals proficient in performing endoscopic hemostasis techniques poses a challenge to market growth. Regulatory hurdles and stringent approval processes for new endoscopic hemostasis devices also impact market expansion. Moreover, the growing preference for minimally invasive surgical techniques and alternative treatment options further intensify competition within the market. Overall, addressing these challenges will be crucial for stakeholders in the Global Endoscopic Hemostasis Market to capitalize on emerging opportunities and drive innovation in the field.
The Global Endoscopic Hemostasis Market is primarily driven by the increasing prevalence of gastrointestinal bleeding disorders, such as peptic ulcers and inflammatory bowel diseases, which require timely and effective hemostasis procedures. Technological advancements in endoscopic devices, such as the development of advanced hemostatic tools and techniques, are also driving market growth by improving the efficacy and safety of endoscopic hemostasis procedures. Additionally, the rising adoption of minimally invasive procedures, growing awareness about the benefits of early diagnosis and treatment of gastrointestinal bleeding, and the expanding geriatric population prone to gastrointestinal disorders are further fueling the demand for endoscopic hemostasis solutions worldwide. Furthermore, favorable reimbursement policies and increasing healthcare expenditures in emerging economies are expected to contribute to the market`s expansion in the coming years.
Government policies related to the Global Endoscopic Hemostasis Market focus on regulating medical devices, ensuring patient safety, and promoting innovation in healthcare. These policies often involve strict approval processes for endoscopic hemostasis devices, adherence to quality standards, and monitoring of adverse events. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in the European Union play a crucial role in overseeing the market and ensuring that endoscopic hemostasis products meet safety and efficacy requirements before they can be commercialized. Additionally, government policies may also aim to promote research and development in the field of endoscopic hemostasis through funding initiatives and collaboration with industry stakeholders to drive advancements in technology and improve patient outcomes.
The Global Endoscopic Hemostasis Market is expected to witness steady growth in the coming years due to the rising prevalence of gastrointestinal bleeding disorders, advancements in endoscopic technology, and increasing adoption of minimally invasive procedures. The market is likely to be driven by the growing aging population, higher incidence of chronic diseases such as peptic ulcers and inflammatory bowel disease, and the expanding demand for endoscopic hemostasis procedures in both developed and developing countries. Additionally, the introduction of innovative hemostasis devices and techniques, along with the rising investments in healthcare infrastructure, will further fuel market growth. However, stringent regulatory requirements and the high cost associated with endoscopic hemostasis procedures may pose challenges to market expansion, requiring industry players to focus on technological advancements and strategic collaborations to maintain a competitive edge.
The Global Endoscopic Hemostasis Market shows varying trends across different regions. In Asia, the market is expected to witness significant growth due to the rising prevalence of gastrointestinal disorders and increasing healthcare infrastructure investments. North America is a mature market with advanced technology adoption and a high awareness of endoscopic procedures, driving market growth. In Europe, the market is driven by the presence of key market players and increasing demand for minimally invasive procedures. The Middle East and Africa region is witnessing a growing adoption of endoscopic hemostasis techniques due to improving healthcare facilities. Latin America shows potential for market expansion driven by increasing healthcare expenditure and a growing patient population. Overall, the global endoscopic hemostasis market is poised for growth across these regions with varying pace and factors influencing market dynamics.
Global Endoscopic Hemostasis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Endoscopic Hemostasis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Endoscopic Hemostasis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Endoscopic Hemostasis Market - Industry Life Cycle |
3.4 Global Endoscopic Hemostasis Market - Porter's Five Forces |
3.5 Global Endoscopic Hemostasis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Endoscopic Hemostasis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Endoscopic Hemostasis Market Revenues & Volume Share, By Indications, 2021 & 2031F |
3.8 Global Endoscopic Hemostasis Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Global Endoscopic Hemostasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Endoscopic Hemostasis Market Trends |
6 Global Endoscopic Hemostasis Market, 2021 - 2031 |
6.1 Global Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Endoscopic Hemostasis Market, Revenues & Volume, By Mechanical Devices, 2021 - 2031 |
6.1.3 Global Endoscopic Hemostasis Market, Revenues & Volume, By Injection Devices, 2021 - 2031 |
6.1.4 Global Endoscopic Hemostasis Market, Revenues & Volume, By Thermal Devices, 2021 - 2031 |
6.1.5 Global Endoscopic Hemostasis Market, Revenues & Volume, By Topical Devices, 2021 - 2031 |
6.2 Global Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Endoscopic Hemostasis Market, Revenues & Volume, By Upper Gastrointestinal Bleeding Diseases, 2021 - 2031 |
6.2.3 Global Endoscopic Hemostasis Market, Revenues & Volume, By Lower Gastrointestinal Bleeding Diseases, 2021 - 2031 |
6.2.4 Global Endoscopic Hemostasis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Endoscopic Hemostasis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Endoscopic Hemostasis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Endoscopic Hemostasis Market, Revenues & Volume, By Ambulatory Centers, 2021 - 2031 |
6.3.5 Global Endoscopic Hemostasis Market, Revenues & Volume, By Surgical Centers, 2021 - 2031 |
6.3.6 Global Endoscopic Hemostasis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Endoscopic Hemostasis Market, Overview & Analysis |
7.1 North America Endoscopic Hemostasis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Endoscopic Hemostasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
7.5 North America Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
8 Latin America (LATAM) Endoscopic Hemostasis Market, Overview & Analysis |
8.1 Latin America (LATAM) Endoscopic Hemostasis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Endoscopic Hemostasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
8.5 Latin America (LATAM) Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
9 Asia Endoscopic Hemostasis Market, Overview & Analysis |
9.1 Asia Endoscopic Hemostasis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Endoscopic Hemostasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
9.5 Asia Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
10 Africa Endoscopic Hemostasis Market, Overview & Analysis |
10.1 Africa Endoscopic Hemostasis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Endoscopic Hemostasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
10.5 Africa Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
11 Europe Endoscopic Hemostasis Market, Overview & Analysis |
11.1 Europe Endoscopic Hemostasis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Endoscopic Hemostasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
11.5 Europe Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
12 Middle East Endoscopic Hemostasis Market, Overview & Analysis |
12.1 Middle East Endoscopic Hemostasis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Endoscopic Hemostasis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Endoscopic Hemostasis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Endoscopic Hemostasis Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Endoscopic Hemostasis Market, Revenues & Volume, By Indications, 2021 - 2031 |
12.5 Middle East Endoscopic Hemostasis Market, Revenues & Volume, By End users, 2021 - 2031 |
13 Global Endoscopic Hemostasis Market Key Performance Indicators |
14 Global Endoscopic Hemostasis Market - Export/Import By Countries Assessment |
15 Global Endoscopic Hemostasis Market - Opportunity Assessment |
15.1 Global Endoscopic Hemostasis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Endoscopic Hemostasis Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Endoscopic Hemostasis Market Opportunity Assessment, By Indications, 2021 & 2031F |
15.4 Global Endoscopic Hemostasis Market Opportunity Assessment, By End users, 2021 & 2031F |
16 Global Endoscopic Hemostasis Market - Competitive Landscape |
16.1 Global Endoscopic Hemostasis Market Revenue Share, By Companies, 2024 |
16.2 Global Endoscopic Hemostasis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |